Bohmert K, Camus I, Bellini C, Bouchez D, Caboche M, Benning C. AGO1 defines a novel locus of Arabidopsis controlling leaf development. EMBO J. 1998;17(1):170–80. https://doi.org/10.1093/emboj/17.1.170.
Sasaki T, Shiohama A, Minoshima S, Shimizu N, Sasaki T, Shiohama A, Minoshima S. Shimizu N Identification of eight members of the Argonaute family in the human genome. Genomics. 2003;82(3):323–30.
Höck J, Meister G. The Argonaute protein family. Genome Biol. 2008;9(2):210. https://doi.org/10.1186/gb-2008-9-2-210.
Meister G. Argonaute proteins: functional insights and emerging roles. Nat Rev Genet. 2013;14(7):447–59. https://doi.org/10.1038/nrg3462.
Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004;305(5689):1437–41. https://doi.org/10.1126/science.1102513.
Tolia NH, Joshua-Tor L. Slicer and the argonautes. Nat Chem Biol. 2007;106(1):36–43.
Song JJ, Smith SK, Hannon GJ, Joshua-Tor L. Crystal structure of Argonaute and its implications for RISC slicer activity. Science. 2004;305(5689):1434–7. https://doi.org/10.1126/science.1102514.
Schirle NT, MacRae IJ. The crystal structure of human Argonaute2. Science. 2012;336(6084):1037–40. https://doi.org/10.1126/science.1221551.
Jinek M, Doudna JA. A three-dimensional view of the molecular machinery of RNA interference. Nature. 2009;457(7228):405–12. https://doi.org/10.1038/nature07755.
Frank F, Sonenberg N, Nagar B. Structural basis for 5′-nucleotide base-specific recognition of guide RNA by human AGO2. Nature. 2010;465(7299):818–22. https://doi.org/10.1038/nature09039.
Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, Shames DS, et al. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol. 2006;13(9):787–92. https://doi.org/10.1038/nsmb1140.
Ameyar-Zazoua M, Rachez C, Souidi M, Robin P, Fritsch L, Young R, et al. Argonaute proteins couple chromatin silencing to alternative splicing. Nat Struct Mol Biol. 2012;19(10):998–1004. https://doi.org/10.1038/nsmb.2373.
Batsché E, Ameyar-Zazoua M. The influence of Argonaute proteins on alternative RNA splicing. Wiley Interdiscip Rev RNA. 2015;6(1):141–56. https://doi.org/10.1002/wrna.1264.
Fu Y, Chen L, Chen C, Ge Y, Kang M, Song Z, et al. Crosstalk between alternative polyadenylation and miRNAs in the regulation of protein translational efficiency. Genome Res. 2018;28(11):1656–63. https://doi.org/10.1101/gr.231506.117.
Berrens RV, Andrews S, Spensberger D, Santos F, Dean W, Gould P, et al. An endosiRNA-based repression mechanism counteracts transposon activation during global DNA demethylation in embryonic stem cells. Cell Stem Cell. 2017;21(5):694–703.e7. https://doi.org/10.1016/j.stem.2017.10.004.
Iwasaki S, Tomari Y. Argonaute-mediated translational repression (and activation). Fly. 2009;3(3):204–6.
Kim BS, Im YB, Jung SJ, Park CH, Kang SK. Argonaute2 regulation for K channel-mediated human adipose tissue-derived stromal cells self-renewal and survival in nucleus. Stem Cells Dev. 2012;21(10):1736–48. +https://doi.org/10.1089/scd.2011.0388.
Wilson RC, Doudna JA. Molecular mechanisms of RNA interference. Ann Rev Biophys. 2013;42:217–39. https://doi.org/10.1146/annurev-biophys-083012-130404.
Bartoszewski R, Sikorski AF. Editorial focus: entering into the non-coding RNA era. Cell Mol Biol Lett. 2018;23:45. https://doi.org/10.1186/s11658-018-0111-3.
Wang Y, Sheng G, Juranek S, Tuschl T, Patel DJ. Structure of the guide-strand-containing Argonaute silencing complex. Nature. 2008;456(7219):209–13. https://doi.org/10.1038/nature07315.
Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell. 2007;129(6):1141–51. https://doi.org/10.1016/j.cell.2007.05.016.
De N, Macrae IJ. Purification and assembly of human Argonaute, Dicer, and TRBP complexes. Methods Mol Biol (Clifton NJ). 2011;725:107–19. https://doi.org/10.1007/978-1-61779-046-1_8.
Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, Lührmann R, et al. Identification of novel Argonaute-associated proteins. Curr Biol. 2005;15(23):2149–55. https://doi.org/10.1016/j.cub.2005.10.048.
Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell. 2007;26(5):611–23. https://doi.org/10.1016/j.molcel.2007.05.001.
Tahbaz N, Kolb FA, Zhang H, Jaronczyk K, Filipowicz W, Hobman TC. Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer. EMBO Rep. 2004;5(2):189–94. https://doi.org/10.1038/sj.embor.7400070.
Lima WF, Wu H, Nichols JG, Sun H, Murray HM, Crooke ST. Binding and cleavage specificities of human Argonaute2. J Biol Chem. 2009;284(38):26017–28. https://doi.org/10.1074/jbc.M109.010835.
Lian SL, Li S, Abadal GX, Pauley BA, Fritzler MJ, Chan EK. The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing. RNA (New York NY). 2009;15(5):804–13. https://doi.org/10.1261/rna.1229409.
Ohana B, Moore PA, Ruben SM, Southgate CD, Green MR, Rosen CA. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc Natl Acad Sci U S A. 1993;90(1):138–42. https://doi.org/10.1073/pnas.90.1.138.
Pollice A, Sepe M, Villella VR, Tolino F, Vivo M, Calabrò V, et al. TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation. Oncogene. 2007;26(35):5154–62. https://doi.org/10.1038/sj.onc.1210313.
Goodkin ML, Ting AT, Blaho JA. NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. J Virol. 2003;77(13):7261–80. https://doi.org/10.1128/jvi.77.13.7261-7280.2003.
Huang W, Wang SL, Lozano G, de Crombrugghe B. cDNA library screening using the SOS recruitment system. BioTechniques. 2001;30(1):94–8. https://doi.org/10.2144/01301st06.
Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. EMBO J. 2006;25(3):522–32. https://doi.org/10.1038/sj.emboj.7600942.
Höck J, Weinmann L, Ender C, Rüdel S, Kremmer E, Raabe M, et al. Proteomic and functional analysis of Argonaute-containing mRNA–protein complexes in human cells. EMBO Rep. 2007;8(11):1052–60. https://doi.org/10.1038/sj.embor.7401088.
Yi T, Arthanari H, Akabayov B, Song H, Papadopoulos E, Qi HH, et al. eIF1A augments Ago2-mediated Dicer-independent miRNA biogenesis and RNA interference. Nat Commun. 2015;6:7194. https://doi.org/10.1038/ncomms8194.
Bottini S, Hamouda-Tekaya N, Mategot R, Zaragosi LE, Audebert S, Pisano S, et al. Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq. Nat Commun. 2017;8(1):1189. https://doi.org/10.1038/s41467-017-01126-x.
Pollice A, Nasti V, Ronca R, Vivo M, Lo Iacono M, Calogero R, et al. Functional and physical interaction of the human ARF tumor suppressor with Tat-binding protein-1. J Biol Chem. 2004;279(8):6345–53. https://doi.org/10.1074/jbc.M310957200.
Ahlenstiel CL, Lim HG, Cooper DA, Ishida T, Kelleher AD, Suzuki K. Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells. Nucleic Acids Res. 2012;40(4):1579–95. https://doi.org/10.1093/nar/gkr891.
Gagnon KT, Corey DR. Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression. Nucleic acid therapeutics. 2012;22(1):3–16. https://doi.org/10.1089/nat.2011.0330.
Ohrt T, Muetze J, Svoboda P, Schwille P. Intracellular localization and routing of miRNA and RNAi pathway components. Curr Top Med Chem. 2012;12(2):79–88. https://doi.org/10.2174/156802612798919132.
Gagnon KT, Li L, Janowski BA, Corey DR. Analysis of nuclear RNA interference in human cells by subcellular fractionation and Argonaute loading. Nat Protoc. 2014;9(9):2045–60. https://doi.org/10.1038/nprot.2014.135.
Corn PG, McDonald ER 3rd, Herman JG, El-Deiry WS. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein. Nat Genet. 2003;35(3):229–37. https://doi.org/10.1038/ng1254.
Rivas FV, Tolia NH, Song JJ, Aragon JP, Liu J, Hannon GJ, et al. Purified Argonaute2 and an siRNA form recombinant human RISC. Nat Struct Mol Biol. 2005;12(4):340–9. https://doi.org/10.1038/nsmb918.
留言 (0)